BioNexus Gene Lab Corp. (BGLC)
undefined
undefined%
At close: undefined
0.35
-5.41%
After-hours Jan 06, 2025, 07:56 PM EST

Ratios (Annual)

Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16
PE Ratio -3.2 -461.48 485.43 216.43 -143.67 1.03K -247.25 -36.64K
PS Ratio 0.86 15.03 27.30 20.79 278.93 128.09 284.15 n/a
PB Ratio 0.87 24.65 50.81 35.54 31.55 17.87 323.35 -23.34K
P/FCF Ratio -5.8 335.34 60.82K 1.81K -153.9 -86.7 721.72 -36.64K
P/OCF Ratio -6.46 301.95 39.83K 428.45 -162.98 -99.23 85.65 -36.64K
OCF/S Ratio -0.13 0.05 0.00 0.05 -1.71 -1.29 3.32 n/a
Debt / Equity Ratio n/a 0.00 0.01 0.01 0.03 n/a n/a n/a
Quick Ratio 4.24 2.52 2.42 2.02 16.97 20.40 0.82 0.02
Current Ratio 4.93 3.00 3.07 2.37 17.11 20.64 0.85 0.02
Asset Turnover 0.86 1.25 1.40 1.13 0.10 0.13 0.08 n/a
Interest Coverage -186.2 -23.33 81.39 112.60 n/a n/a n/a n/a
Return on Equity (ROE) -0.27 -0.05 0.10 0.16 -0.22 0.02 -1.31 0.64
Return on Assets (ROA) -0.23 -0.04 0.08 0.11 -0.2 0.02 -0.1 -32.12
Return on Capital (ROIC) -0.27 -0.04 0.15 0.19 -0.23 0.04 -1.29 0.64
Dividend Yield n/a 0.00 0.00 0.00 n/a n/a n/a n/a
Payout Ratio n/a -0.32 0.03 0.01 n/a n/a n/a n/a
Gross Profit Margin 13.61% 11.52% 16.42% 15.10% 44.02% 13.55% 73.19% n/a
Net Profit Margin -26.91% -3.26% 5.62% 9.61% -194.14% 12.46% -114.92% n/a
Pretax Profit Margin -26.69% -2.78% 7.80% 11.08% -217.17% 28.21% -110.9% n/a
Operating Profit Margin -26.54% -2.66% 7.90% 11.18% -217.17% 28.21% -118.79% n/a
FCF Margin -14.85% 4.48% 0.04% 1.15% -181.24% -147.74% 39.37% n/a
EBITDA Margin -25.43% -1.7% 8.71% 12.08% -175.16% 47.34% -96.94% n/a

Create Price Alert on BGLC

Your price alert will notify you when the stock price is above 0.37.

Add to Watchlist